ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
China approves Gilead’s HIV-1 drug candidate Biktarvy
August 13, 2019The China National Medical Products Administration (NMPA) has approved Gilead Sciences’ Biktarvy, a once-daily single-tablet regimen (STR) to treat HIV-1 infection. -
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate
December 19, 2018Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company signed a license agreement with ....
Pharma Sources Insight January 2025
